Epzicom FDA Approval History
FDA Approved: Yes (First approved August 2, 2004)
Brand name: Epzicom
Generic name: abacavir and lamivudine
Dosage form: Tablets
Company: ViiV Healthcare
Treatment for: HIV Infection
Epzicom (abacavir and lamivudine) is a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) indicated for use with other antiretroviral drugs for the treatment of HIV-1 infection in adults.
Development timeline for Epzicom
| Date | Article |
|---|---|
| Aug 2, 2004 | Approval Epzicom GlaxoSmithKline - Treatment for HIV Infection |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
